News
The prestigious Science Awards of the State of Lower Austria were presented at the Wissenschaftsgala 2024 in the Moonstone Building at the Institute of Science and Technology Austria (ISTA) on Wednesday, 9 October 2024. Two researchers from Karl Landsteiner University of Health Sciences (KL Krems) were honoured for their outstanding scientific contributions.
A groundbreaking success in the fight against hepatitis C: As part of the cross-institutional ELIMINATE project, hospital data was systematically analyzed in ten hospitals in Vienna (including 6 WIGEV clinics) and Lower Austria in order to identify and treat those affected. As a result, almost 400 patients were cured of their chronic hepatitis C disease using modern therapies.
Real data is required for the development of AI applications. For so-called vulnerable target groups, for example in the long-term care sector, this data is partly generated artificially by simulation, as there is still little real data material on age(ing).
Take part in the stem cell typing campaign at Karl Landsteiner University on 9 October 2024 (11 a.m. - 2 p.m.). A small cheek swab is all it takes to become a potential lifesaver for people suffering from blood cancer.
In Europe, incidences of severe native valvular heart disease (VHD) and their treatment vary between men and women.
On the initiative of the MedAustron Ion Therapy and Research Center, 80 experts in radiation therapy with protons and carbon ions came together at KL Krems to set the strategic course for the future of this form of therapy at the second “World Forum on Particle Therapy”.
On 3 June 2024, the first INTA symposium took place at the Linz campus of the University of Applied Sciences Upper Austria on the topic of "Technology in old age: possibilities and limits of AI and big data". Around 28 network partners from all over Austria took part in the event - including co-founder of INTA, Univ.-Prof. Dr phil. habil. Giovanni Rubeis, Head of the Division of Biomedical Ethics and Healthcare Ethics at KL Krems, as well as Dr Vera Gallistl and Katrin Lehner BA MA from the Division of Gerontology and Ageing Research at KL Krems.
Bereits zum 9. Mal war die KL als Projektpartnerin der IMC FH bei der Jungen Uni dabei. Über 100 Kinder und Jugendliche zwischen 10 und 13 Jahren nahmen am 11. Juli 2024 – dem „Gesundheitstag“ – am abwechslungsreichen Programm der KL teil und tauchten in die spannende Welt der Medizin und Psychologie ein.
Investigating haematopoietic and solid tumours
The protein STAT3 helps the immune system to recognise leukemic cells. This interaction, which is important for future immunotherapies, is now understood in detail thanks to a study at the Karl Landsteiner University of Health Sciences (KL Krems). The study showed that STAT3 influences the formation of surface structures on leukemic cells that make them vulnerable to the immune system. If these structures are missing, leukemic cells can escape the body's innate immune surveillance. The expression of STAT3 in and the surface structures on leukemic cells could be a potential biomarker for future immunotherapies.